BOK Financial Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
1,258
-531
| -30% | -$236K | 0.04% | 117 |
|
|
2025
Q1 | $867K | Sell |
1,789
-194
| -10% | -$94.1K | 0.07% | 98 |
|
|
2024
Q4 | $799K | Sell |
1,983
-374
| -16% | -$151K | 0.06% | 106 |
|
|
2024
Q3 | $1.1M | Sell |
2,357
-236
| -9% | -$110K | 0.08% | 99 |
|
|
2024
Q2 | $1.22M | Sell |
2,593
-22
| -0.8% | -$10.3K | 0.09% | 98 |
|
|
2024
Q1 | $1.09M | Sell |
2,615
-476
| -15% | -$199K | 0.08% | 99 |
|
|
2023
Q4 | $1.26M | Sell |
3,091
-325
| -10% | -$132K | 0.1% | 92 |
|
|
2023
Q3 | $1.19M | Sell |
3,416
-806
| -19% | -$280K | 0.1% | 93 |
|
|
2023
Q2 | $1.49M | Sell |
4,222
-767
| -15% | -$270K | 0.12% | 88 |
|
|
2023
Q1 | $1.57M | Buy |
4,989
+604
| +14% | +$190K | 0.13% | 91 |
|
|
2022
Q4 | $1.27M | Buy |
+4,385
| New | +$1.27M | 0.11% | 92 |
|
|
2022
Q2 | – | Sell |
-1,405
| Closed | -$367K | – | 459 |
|
|
2022
Q1 | $367K | Buy |
1,405
+355
| +34% | +$92.7K | 0.03% | 205 |
|
|
2021
Q4 | $231K | Buy |
+1,050
| New | +$231K | 0.02% | 268 |
|